Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,150.00    11.00 (0.97%)
Bid:
1,149.00
Ask:
1,150.00
Spread: 1.00 (0.087%)
Market Cap: £9.76b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

9 May 2019 15:14

RNS Number : 5624Y
Smith & Nephew Plc
09 May 2019
 

 

SMITH & NEPHEW PLC

 

9 May 2019

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Graham Baker

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Smith & Nephew plc

b)

LEI

213800ZTMDN8S67S1H61

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Smith & Nephew plc ordinary shares of USD 0.20 each

 

ISIN: GB0009223206

b)

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2018 final dividend payment on 8 May 2019.

c)

Price(s) and volume(s)

Price(s)

£16.2523

Volume(s)

26

d)

Aggregated information

- Aggregated volume

- Price

Single Transaction

N/A

N/A

e)

Date of the transaction

2019 - 05 - 09

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Anne-Marie Baker

2

Reason for the notification

a)

Position/status

PCA of Graham Baker, Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Smith & Nephew plc

b)

LEI

213800ZTMDN8S67S1H61

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Smith & Nephew plc ordinary shares of USD 0.20 each

 

ISIN: GB0009223206

b)

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2018 final dividend payment on 8 May 2019.

c)

Price(s) and volume(s)

Price(s)

£16.2527

£16.1335

Volume(s)

15

63

d)

Aggregated information

- Aggregated volume

- Price

 

78

£16.1564

e)

Date of the transaction

2019 - 05 - 09

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Susan Swabey

Company Secretary

Smith & Nephew plc

 

Tel: 01923 477216

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFLSEFIAIIA
Date   Source Headline
26th Apr 20237:00 amRNSQ1 2023 Trading Update
6th Apr 20237:00 amRNSNotice of First Quarter 2023 Trading Report
3rd Apr 20232:07 pmRNSTotal Voting Rights
13th Mar 20231:45 pmRNSDirector/PDMR Shareholding
6th Mar 20236:00 pmRNSAnnual Financial Report
1st Mar 20232:44 pmRNSTotal Voting Rights
22nd Feb 20231:07 pmRNSDirector/PDMR Shareholding
21st Feb 20231:41 pmRNSDirector/PDMR Shareholding
21st Feb 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
1st Feb 20234:15 pmRNSBlock listing Interim Review
1st Feb 202311:20 amRNSTotal Voting Rights
26th Jan 202312:22 pmRNSNotice of Results
19th Jan 20233:19 pmRNSDirector/PDMR Shareholding
3rd Jan 20231:47 pmRNSTotal Voting Rights
12th Dec 20224:37 pmRNSDirector/PDMR Shareholding
9th Dec 202211:30 amRNSDirector/PDMR Shareholding
1st Dec 20222:00 pmRNSTotal Voting Rights
16th Nov 202211:30 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNS3rd Quarter 2022 Trading Report
1st Nov 202210:38 amRNSTotal Voting Rights
28th Oct 202211:45 amRNSDirector/PDMR Shareholding
14th Oct 20227:01 amRNSDividend Declaration
14th Oct 20227:00 amRNSTiming of Smith & Nephew Q3 2022 Trading Update
5th Oct 20227:00 amRNSEuro Bond Issue
3rd Oct 202212:53 pmRNSTotal Voting Rights
14th Sep 20223:00 pmRNSDirector/PDMR Shareholding
1st Sep 20221:33 pmRNSTotal Voting Rights
1st Sep 20227:00 amRNSBoard Committee Membership
23rd Aug 20225:05 pmRNSDirector/PDMR Shareholding
23rd Aug 20224:25 pmRNSDirector/PDMR Shareholding
16th Aug 20224:57 pmRNSDirector/PDMR Shareholding
12th Aug 20225:40 pmRNSTransaction in Own Shares
12th Aug 20224:45 pmRNSDirector/PDMR Shareholding
11th Aug 20226:21 pmRNSTransaction in Own Shares
10th Aug 20226:06 pmRNSTransaction in Own Shares
9th Aug 20226:16 pmRNSTransaction in Own Shares
9th Aug 202211:00 amRNSAdditional Listing
8th Aug 20222:09 pmRNSTransaction in Own Shares
1st Aug 20226:15 pmRNSBlock listing Interim Review
1st Aug 20221:15 pmRNSTotal Voting Rights
28th Jul 20227:00 amRNSHalf-year Report
18th Jul 20222:30 pmRNSDirector/PDMR Shareholding
6th Jul 202211:27 amRNSNotice of Results
1st Jul 202211:36 amRNSTotal Voting Rights
20th Jun 20227:00 amRNSDirectorate Change
9th Jun 20227:00 amRNSTransaction in Own Shares
1st Jun 20222:21 pmRNSTotal Voting Rights
24th May 20222:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.